U.S. Markets closed

AbbVie set to buy Botox-maker Allergan in $63 billion deal

Allergan will be bought by AbbVie in a cash and stock deal valued at about $63 billion. Yahoo Finance's Alexis Christoforous and Brian Sozzi speak to Scott Gamm.